| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |